← Open Payments lookup

TRACI FICHTER: Open Payments

NPI 1154395929 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$888 in 46 payments from 15 companies in 2025. Trend: 2023 $800 · 2024 $1,257 · 2025 $888

Food & beverage: $888
CompanyPaymentsAmount
ABBVIE INC.10$207
Janssen Biotech, Inc.9$172
Madrigal Pharmaceuticals8$154
GENZYME CORPORATION2$66
Regeneron Healthcare Solutions, Inc.3$52
Gilead Sciences, Inc.2$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$39
Celltrion USA Inc.2$33
Takeda Pharmaceuticals U.S.A., Inc.1$24
Novo Nordisk Inc1$19

Products named: TREMFYA, REZDIFFRA, DUPIXENT, LINZESS, CREON, RINVOQ, XIFAXAN, VEGZELMA.

Industry payments across NE — which companies pay providers there.